Obecabtagene autoleucel (obe-cel)
AUTO1-MS1
Phase 1 mab active
Quick answer
Obecabtagene autoleucel (obe-cel) for Progressive Multiple Sclerosis is a Phase 1 program (mab) at Autolus Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Autolus Therapeutics plc
- Indication
- Progressive Multiple Sclerosis
- Phase
- Phase 1
- Modality
- mab
- Status
- active